MARÍA JOSÉ
SÁNCHEZ PÉREZ
DOCENTE INVITADA
National Institute for Health Development
Tallin, EstoniaPublicaciones en colaboración con investigadores/as de National Institute for Health Development (22)
2024
-
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
The Lancet Oncology, Vol. 25, Núm. 3, pp. 293-307
-
Differences in survival and recurrence of colorectal cancer by stage across population-based European registries
International Journal of Cancer, Vol. 155, Núm. 5, pp. 807-815
2022
-
Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations
Cancers, Vol. 14, Núm. 18
-
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431
2021
-
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645
2020
-
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study
European Journal of Surgical Oncology, Vol. 46, Núm. 6, pp. 1151-1159
-
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Breast Cancer Research and Treatment, Vol. 183, Núm. 2, pp. 439-450
2019
-
Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer
International Journal of Cancer, Vol. 144, Núm. 9, pp. 2118-2127
2018
-
Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
European Journal of Cancer, Vol. 93, pp. 127-137
2017
-
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
The Lancet Oncology, Vol. 18, Núm. 8, pp. 1022-1039
-
Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, Vol. 82, pp. 137-148
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353
2015
-
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2206-2216
-
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2191-2205
-
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2104-2119
-
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230
2014
-
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34
-
Childhood cancer survival in Europe 1999-2007: Results of EUROCARE-5-a population-based study
The Lancet Oncology, Vol. 15, Núm. 1, pp. 35-47